Retatrutide 30 mg

RT-2026-043Lot CP01260929230XAnalyzed October 29, 2026

Timeline

Ordered

October 24, 2026

Received

October 28, 2026

Analyzed

October 29, 2026

Sample

Name

Retatrutide 30 mg

Expected

Retatrutide

Amount

1 vial, lyophilized powder

Testing

Client

Lab2Vial

Test type

Content & purity

Method

HPLC-UV

Group test

Vials tested

1 vial, shared result

Contributors

3 people

Shared by

Jose Gonzalez, Andre, Dustin Ogando

Content, how much is in it

30.74mg

Label claim: 30 mg

Purity, how clean it is

>99.9%

by HPLC-UV peak area

Chromatogram

HPLC-UV

18.00 min, Retatrutide, >99.9%

Analyst Comments

White lyophilized powder, blue-cap vial, received sealed. Unlabeled vial; label claim taken from the order.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: October 29, 2026

Verification Code

RT-LRDR-B8EZ

Verify at purilab.org/verify/RT-LRDR-B8EZ

Scan to Verify

RT-LRDR-B8EZ

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1